EphB4 has been found overexpressed in malignant cancer cells where it has been associated to a variety of cancer-promoting effects, including morphogenesis, angiogenesis, invasion, and metastasis [4–8] and its pharmacologic block or kinase activity deficiency counteracts such effects [9, 10]. Here, EPHB4 is linked to cancer.